Received Sep 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (NOVAVAX)) | NOVAVAX | UNK | 4302MF023 | OT |
Fever; Chills; Possibly sore throat; Tested positive for COVID-19; This non serious initial spontaneous report was reported by a consumer or other non-health professional via contact center and concerns a 71-year-old Female who experienced "FEVER", "CHILLS", "POSSIBLY SORE THROAT", and "Tested positive for COVID-19" on unspecified dates after receiving Novavax COVID-19 Vaccine, Adjuvanted, on an unspecified date in Oct 2022. At the time of the report, the outcome of the Pyrexia, Chills, Oropharyngeal pain, and SARS-CoV-2 test positive was Recovered/Resolved (Unspecified date).; Sender's Comments: This 71-year-old Female experienced Pyrexia, Chills, Oropharyngeal pain, and SARS-CoV-2 test positive after vaccination with Novavax COVID-19 Vaccine, Adjuvanted. The event Pyrexia was reported as non-serious. The event Chills was reported as non-serious. The event Oropharyngeal pain was reported as non-serious. The event SARS-CoV-2 test positive was reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between Novavax COVID-19 Vaccine, Adjuvanted and Pyrexia, Chills, Oropharyngeal pain and SARS-CoV-2 test positive is considered Possible.
Drug hypersensitivity; Immunodeficiency; Pernicious anemia; Radiotoxicity; Tumor
Medical History/Concurrent Conditions: SARS-CoV-2 test positive
B12 injection
Test Name: COVID-19 TEST; Result Unstructured Data: Positive